1. Home
  2. PRSO vs BFRI Comparison

PRSO vs BFRI Comparison

Compare PRSO & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$0.37

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$0.82

Market Cap

12.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSO
BFRI
Founded
2008
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
12.3M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
PRSO
BFRI
Price
$0.37
$0.82
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $6.00
AVG Volume (30 Days)
137.9K
★ 342.0K
Earning Date
11-09-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 81.23
67.70
EPS
★ N/A
N/A
Revenue
$14,573,000.00
★ $41,705,000.00
Revenue This Year
N/A
$10.65
Revenue Next Year
$191.73
$15.88
P/E Ratio
N/A
★ N/A
Revenue Growth
5.99
★ 11.75
52 Week Low
$0.36
$0.57
52 Week High
$2.10
$1.66

Technical Indicators

Market Signals
Indicator
PRSO
BFRI
Relative Strength Index (RSI) 27.37 29.43
Support Level N/A $0.74
Resistance Level $0.52 $0.97
Average True Range (ATR) 0.03 0.08
MACD -0.00 -0.01
Stochastic Oscillator 8.84 0.50

Price Performance

Historical Comparison
PRSO
BFRI

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices, and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz to 300 GHz. Geographically, the company generates revenue from the United States, Hong Kong, Taiwan, Europe, and the Rest of the World.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Share on Social Networks: